Insider · CIK 0001606244
Carlos Paya V
Files at COLL (COLLEGIUM PHARMACEUTICAL, INC), PCVX (Vaxcyte, Inc.). First filing -, latest -.
Carlos Paya V files SEC Form 4 as director at COLL (COLLEGIUM PHARMACEUTICAL, INC), and also at PCVX (Vaxcyte, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Carlos Paya V has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +2,265 | $0.00 | $0 | 6,856 | Jun 16, 2026 |
| Jun 15, 2026 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,389 | $0.00 | $0 | 11,389 | Jun 16, 2026 |
| May 14, 2026 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +8,741 | $0.00 | $0 | 28,323 | May 18, 2026 |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Common Stock | +3,041 | $0.00 | $0 | 4,591 | Jun 16, 2025 |
| Jun 12, 2025 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivative | +15,372 | $0.00 | $0 | 15,372 | Jun 16, 2025 |
| May 15, 2025 | COLL COLLEGIUM PHARMACEUTICAL, INC | AGrant or award Common Stock | +19,582 | $0.00 | $0 | 19,582 | May 19, 2025 |
| Dec 6, 2024 | PCVX Vaxcyte, Inc. | GGift Common Stock | -2,500 | $0.00 | $0 | 1,550 | Dec 10, 2024 |
| Dec 6, 2024 | PCVX Vaxcyte, Inc. | AGrant or award Common Stockindirect: By Family Trust | +2,500 | $0.00 | $0 | 5,625 | Dec 10, 2024 |
| Dec 9, 2024 | PCVX Vaxcyte, Inc. | GGift Stock Option (right to buy)derivative | -7,250 | $0.00 | $0 | 0 | Dec 10, 2024 |
| Dec 9, 2024 | PCVX Vaxcyte, Inc. | AGrant or award Stock Option (right to buy)derivativeindirect: By Family Trust | +7,250 | $0.00 | $0 | 7,250 | Dec 10, 2024 |
Questions about Carlos Paya V
Answered from the filings on this page, as of the latest one.
Is Carlos Paya V buying or selling?
Carlos Paya V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Carlos Paya V's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Carlos Paya V has 0.
Where does Carlos Paya V file Form 4?
Carlos Paya V has filed Form 4 at COLL (COLLEGIUM PHARMACEUTICAL, INC); PCVX (Vaxcyte, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.